{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:00:26Z","timestamp":1770904826491,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.07.092","type":"journal-article","created":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T07:28:41Z","timestamp":1564817321000},"page":"5596-5606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Wisam Salim","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula R.","family":"Giaretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Rech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Ollivault-Shiflett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-2794","authenticated-orcid":false,"given":"Maria D.","family":"Esteve-Gasent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.07.092_b0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2014.09.004","article-title":"Lyme disease: a rigorous review of diagnostic criteria and treatment","volume":"57","author":"Borchers","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0010","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1126\/science.8503006","article-title":"The biological and social phenomenon of Lyme disease","volume":"260","author":"Barbour","year":"1993","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.vaccine.2019.07.092_b0015","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1128\/IAI.72.10.5759-5767.2004","article-title":"Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses","volume":"72","author":"Liang","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2004.10.027","article-title":"TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi","volume":"119","author":"Pal","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.07.092_b0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/iai.41.2.795-804.1983","article-title":"Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody","volume":"41","author":"Barbour","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/iai.45.1.94-100.1984","article-title":"Variation in a major surface protein of Lyme disease spirochetes","volume":"45","author":"Barbour","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.3969554","article-title":"A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete","volume":"227","author":"Howe","year":"1985","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.vaccine.2019.07.092_b0040","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/JB.00085-08","article-title":"Reciprocal expression of ospA and ospC in single cells of Borrelia burgdorferi","volume":"190","author":"Srivastava","year":"2008","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1099\/jmm.0.05068-0","article-title":"Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi","volume":"52","author":"Gilmore","year":"2003","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4161\/hv.4661","article-title":"An octavalent Lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences","volume":"3","author":"Earnhart","year":"2007","journal-title":"Human Vac"},{"key":"10.1016\/j.vaccine.2019.07.092_b0055","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CVI.00409-06","article-title":"OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine","volume":"14","author":"Earnhart","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4161\/hv.4661","article-title":"An octavalent Lyme disease vaccine induces antibodies that recognize all incorporated ospC type-specific sequences","volume":"3","author":"Earnhart","year":"2014","journal-title":"Human Vac"},{"key":"10.1016\/j.vaccine.2019.07.092_b0065","article-title":"Vanguard\u00ae crLyme: chimeric recombinant vaccine technology for broad-spectrum protection against canine Lyme","author":"Ball","year":"2015","journal-title":"Disease"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.07.092_b0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1469-0691.2012.03939.x","article-title":"Developing vaccines in the era of genomics: a decade of reverse vaccinology","volume":"18","author":"Seib","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2019.07.092_b0075","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2019.07.092_b0080","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1073\/pnas.0506758102","article-title":"Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: Implications for the microbial \u201cpan-genome\u201d","volume":"102","author":"Tettelin","year":"2005","journal-title":"Proc Nat Acad Scie U S A"},{"key":"10.1016\/j.vaccine.2019.07.092_b0085","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/gb-2007-8-5-r71","article-title":"Evolution of the core and pan-genome of Streptococcus: positive selection, recombination, and genome composition","volume":"8","author":"Lefebure","year":"2007","journal-title":"Genome Biol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0090","doi-asserted-by":"crossref","first-page":"e88245","DOI":"10.1371\/journal.pone.0088245","article-title":"Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against Lyme disease","volume":"9","author":"Small","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.092_b0095","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1128\/JB.00187-13","article-title":"BB0172, a Borrelia burgdorferi outer membrane protein that binds integrin alpha3beta1","volume":"195","author":"Wood","year":"2013","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0100","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Human Vac Immunother"},{"key":"10.1016\/j.vaccine.2019.07.092_b0105","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.2527\/2001.79102524x","article-title":"Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance","volume":"79","author":"Dunshea","year":"2001","journal-title":"J Ani Sci"},{"key":"10.1016\/j.vaccine.2019.07.092_b0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0001-37652005000200009","article-title":"Vaccines based on the cell surface carbohydrates of pathogenic bacteria","volume":"77","author":"Jones","year":"2005","journal-title":"An Acad Bras Cienc"},{"key":"10.1016\/j.vaccine.2019.07.092_b0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/IAI.01118-07","article-title":"Role of the BBA64 locus of Borrelia burgdorferi in early stages of infectivity in a murine model of Lyme disease","volume":"76","author":"Maruskova","year":"2008","journal-title":"Infect Immun."},{"key":"10.1016\/j.vaccine.2019.07.092_b0120","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2958.2008.06549.x","article-title":"sodA is essential for virulence of Borrelia burgdorferi in the murine model of Lyme disease","volume":"71","author":"Esteve-Gassent","year":"2009","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0125","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/IAI.69.1.446-455.2001","article-title":"Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28\u20131","volume":"69","author":"Labandeira-Rey","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0130","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.162.2.948","article-title":"Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease","volume":"162","author":"Weis","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0135","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/j.1365-2958.2005.05042.x","article-title":"Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi","volume":"59","author":"Seshu","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0140","first-page":"96","article-title":"Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi","volume":"1","author":"Conlon","year":"2000","journal-title":"Vet Therapeut"},{"key":"10.1016\/j.vaccine.2019.07.092_b0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CVI.00373-08","article-title":"Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease","volume":"16","author":"LaFleur","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0150","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1128\/IAI.66.11.5379-5387.1998","article-title":"DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies","volume":"66","author":"Cassatt","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0155","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1128\/IAI.66.6.2827-2835.1998","article-title":"Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice","volume":"66","author":"Feng","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0160","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1016\/j.vaccine.2011.09.035","article-title":"Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine","volume":"29","author":"Kumar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.092_b0165","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/iai.53.3.713-714.1986","article-title":"Passive immunization of hamsters against experimental infection with the Lyme disease spirochete","volume":"53","author":"Johnson","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0170","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1128\/AEM.01649-10","article-title":"Elimination of Lyme disease spirochetes from ticks feeding on domestic ruminants","volume":"76","author":"Richter","year":"2010","journal-title":"Appl Environm Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0175","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/CVI.05226-11","article-title":"Reservoir targeted vaccine for Lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice","volume":"18","author":"Meirelles Richer","year":"2011","journal-title":"Clin Vac Immunol."},{"key":"10.1016\/j.vaccine.2019.07.092_b0180","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2013serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.092_b0185","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/erv.12.32","article-title":"MenACWY-TT vaccine for active immunization against invasive meningococcal disease","volume":"11","author":"Papaevangelou","year":"2012","journal-title":"Expert Rev Vac"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.07.092_b0190","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/j.vaccine.2011.12.060","article-title":"History of meningococcal vaccines and their serological correlates of protection","volume":"30","author":"Vipond","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.092_b0195","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.vaccine.2017.03.066","article-title":"Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines","volume":"35","author":"Beresford","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.092_b0200","doi-asserted-by":"crossref","first-page":"e18220-e","DOI":"10.1371\/journal.pone.0018220","article-title":"Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans","volume":"6","author":"Sj\u00f6wall","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2019.07.092_b0205","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/iai.65.8.3107-3111.1997","article-title":"T-helper-cell cytokines in the early evolution of murine Lyme arthritis","volume":"65","author":"Kang","year":"1997","journal-title":"Infect Immun."},{"key":"10.1016\/j.vaccine.2019.07.092_b0210","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1086\/382893","article-title":"Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome","volume":"189","author":"Widhe","year":"2004","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2019.07.092_b0215","series-title":"Advances in Protein Chemistry and Structural Biology","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.apcsb.2015.03.004","article-title":"Chapter four - perspective of peptide vaccine composed of epitope peptide, CpG-DNA, and liposome complex without carriers","author":"Lee","year":"2015"},{"key":"10.1016\/j.vaccine.2019.07.092_b0220","doi-asserted-by":"crossref","first-page":"2657+","DOI":"10.2217\/nnm.14.187","article-title":"Recent advances in peptide-based subunit nanovaccines","volume":"9","author":"Skwarczynski","year":"2014","journal-title":"Nanomed"},{"key":"10.1016\/j.vaccine.2019.07.092_b0225","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/00006454-199809001-00005","article-title":"Haemophilus influenzae type b conjugate vaccines: a review of efficacy data","volume":"17","author":"Heath","year":"1998","journal-title":"The Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.07.092_b0230","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1016\/j.vaccine.2017.04.078","article-title":"Polysaccharide conjugate vaccine protein carriers as a \u201cneglected valency\u201d \u2013 potential and limitations","volume":"35","author":"Br\u00f6ker","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.092_b0235","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2015.01.046","article-title":"Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines","volume":"33","author":"Lockyer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.092_b0240","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/iai.43.2.710-714.1984","article-title":"Production and characterization of monoclonal antibodies to tetanus toxin","volume":"43","author":"Sheppard","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0245","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1128\/iai.45.3.604-609.1984","article-title":"Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule","volume":"45","author":"Volk","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0250","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/eji.1830230219","article-title":"The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86","volume":"23","author":"Demotz","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jmb.2006.09.050","article-title":"The HC fragment of tetanus toxin forms stable, concentration-dependent dimers via an intermolecular disulphide bond","volume":"365","author":"Qazi","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0260","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1128\/iai.59.5.1627-1632.1991","article-title":"Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system","volume":"59","author":"Charles","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.092_b0265","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/315324","article-title":"Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins","volume":"181","author":"Diethelm-Okita","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.092_b0270","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.88.10.4538","article-title":"Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production","volume":"88","author":"Parronchi","year":"1991","journal-title":"Proceed Nati Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.07.092_b0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0300-9475.2004.01362.x","article-title":"Hoiby EA. The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis","volume":"59","author":"Michaelsen","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0280","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/eji.1830050807","article-title":"Role of epitope density in the induction of immunity and tolerance with thymus-independent antigens. II. studies with 2,4-dinitrophenyl conjugates in vivo","volume":"5","author":"Desaymard","year":"1975","journal-title":"EurJ Immunol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0285","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.vaccine.2019.07.092_b0290","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J","article-title":"Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation","volume":"32","author":"Jegerlehner","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0295","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/cb600489g","article-title":"Activating B cell signaling with defined multivalent ligands","volume":"2","author":"Puffer","year":"2007","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0300","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/cbic.201000235","article-title":"Effects of hapten density on the induced antibody repertoire","volume":"11","author":"Li","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1016\/j.vaccine.2019.07.092_b0305","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal c conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.092_b0310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/hv.1.4.2018","article-title":"Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology","volume":"1","author":"Pollabauer","year":"2005","journal-title":"Human Vac."},{"key":"10.1016\/j.vaccine.2019.07.092_b0315","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1128\/IAI.71.6.3371-3383.2003","article-title":"Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals","volume":"71","author":"Brooks","year":"2003","journal-title":"Infect Immun."},{"key":"10.1016\/j.vaccine.2019.07.092_b0320","doi-asserted-by":"crossref","unstructured":"MJ. Caimano. Cultivation of Borrelia burgdorferi in dialysis membrane chambers in rat peritonea. Current protocols in microbiology. 2005;Chapter 12:Unit 12C.3.","DOI":"10.1002\/9780471729259.mc12c03s00"},{"key":"10.1016\/j.vaccine.2019.07.092_b0325","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.4049\/jimmunol.154.4.1770","article-title":"T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice","volume":"154","author":"Keane-Myers","year":"1995","journal-title":"J Immunol."},{"key":"10.1016\/j.vaccine.2019.07.092_b0330","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/JCM.39.11.4145-4148.2001","article-title":"Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors","volume":"39","author":"Piesman","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0335","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4269\/ajtmh.1995.53.397","article-title":"Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding","volume":"53","author":"De Silva","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.07.092_b0340","doi-asserted-by":"crossref","first-page":"153","DOI":"10.14411\/fp.2002.027","article-title":"Tick salivary gland extract-activated transmission of Borrelia afzelii spirochaetes","volume":"49","author":"Pechova","year":"2002","journal-title":"Folia Parasitol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0345","first-page":"1276","article-title":"Gern L, Piesman J. Coinoculation of Borrelia spp. with tick salivary gland lysate enhances spirochete load in mice and is tick species-specific","volume":"88","author":"Zeidner","year":"2002","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2019.07.092_b0350","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13071-016-1380-1","article-title":"Virulence of the Lyme disease spirochete before and after the tick bloodmeal: a quantitative assessment","volume":"9","author":"Kasumba","year":"2016","journal-title":"Parasit Vector"},{"key":"10.1016\/j.vaccine.2019.07.092_b0355","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(02)00325-4","article-title":"Salp15, an Ixodes scapularis salivary protein, inhibits CD4(+) T cell activation","volume":"16","author":"Anguita","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2019.07.092_b0360","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nature03812","article-title":"The Lyme disease agent exploits a tick protein to infect the mammalian host","volume":"436","author":"Ramamoorthi","year":"2005","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:52Z","timestamp":1759401232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19310138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":72,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19310138"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}